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Background
Leptospirosis is an emergent zoonotic disease caused by
pathogenic Leptospira spp., and humans are regarded as
an accidental or dead-end host [1]. The global incidence
of severe human leptospirosis was estimated to be
approximately 500.000 cases worldwide, although this is
likely an underestimate due to the lack of a reliable diag-
nostic test. Mortality ranges from 10 to > 50% for Weil’s
disease or severe pulmonary hemorrhage syndrome
(SPHS), respectively [2]. The microscopic agglutination
test (MAT) is the standard test for this disease, however, it
requires paired serum samples, is laborious, difficult to
analyze and subjective [3]. Apart from the danger con-
nected with rodents, which are the main vectors of leptos-
pires, occurrence of the disease in dogs can generate a
higher risk of infection for humans. Thus, a novel sensitive
and specific serological test providing a rapid and secure
diagnosis is urgently required for the laboratorial diagnosis
of leptospirosis. In this study, 15 recombinant proteins
from L. interrogans were expressed, purified and evaluated
in an indirect ELISA using canine sera that were charac-
terized by the MAT and a whole-cell Leptospira ELISA.
Methods
Fifteen recombinant polypeptides based on LigB, LigA
LipL32, LemA, OmpL37, FlaA1 and FlaB1 were cloned
and expressed in Escherichia coli, purified by Ni2+affinity
chromatography, quantified and stored at -20 ºC until use.
The recombinant proteins were assessed in a checker-
board ELISA to evaluate their capability discriminate
between infected and non-infected canine sera, and to
determine the optimal combinations of antigen, canine
sera and anti-dog IgG and IgM HRP conjugate antibodies.
After the initial screening, two recombinant proteins were
selected and tested against a serum panel, 10 positive and
10 negative serum samples.
Results and conclusions
Following the preliminary screening using pooled sera,
rLigBrep and rLipL32 were evaluated using a panel of
individual canine serum samples. The optimal concen-
trations of antigen for the coating step was 100 ng/well.
The optimal sera dilution was 1:200 for rLigBrep, 1:100
for rLipL32, 1:2500 for the IgG and 1:5000 for the IgM
conjugates. Based on the negative sera, the average OD
for rLigBrep was 0.24 ± 0.11 for the negative pool and
the cut-off was calculated as OD = 0.47. 100% of the
negative sera were negative and 70% of the characterized
positive were identified as positive under these condi-
tions. The average OD based on rLipL32 was 0.2 ± 0.08
for the negative pool, equivalent to a cut-off of OD =
0.36. 100% of negative sera were negative and 50% posi-
tive sera were identified as positive. The anti-dog-IgG
conjugate exhibited the best specificity and sensitivity.
The recombinant protein rLigBrep demonstrated poten-
tial as a diagnostic tool for canine leptospirosis, 70.0%
sensitivity and 100% specificity. The native protein,
LigB, is highly conserved in pathogenic Leptospira spp.
and therefore represents an ideal candidate for further
studies.
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